Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)

Overview of attention for article published in Journal of Translational Medicine, January 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

METHOD FOR THE TREATMENT OF MALIGNANCIES

Application EP-3881860-A1

European Patent Office

MODULATING RESPONSES TO CHECKPOINT INHIBITOR THERAPY

Application EP-3515472-A4

European Patent Office

PLASMID CONSTRUCTS FOR HETEROLOGOUS PROTEIN EXPRESSION AND METHODS OF USE

Application EP-3390643-A4

European Patent Office

METHOD FOR THE TREATMENT OF MALIGNANCIES

Application EP-3286311-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.